Drug Transporter (DT) Information

General Information of DT
DT ID DTD0185
Gene Name SLC25A24
Protein Name Calcium-binding mitochondrial carrier protein SCaMC-1
Gene ID
29957
UniProt ID
Q6NUK1
TCDB ID
2.A.29.23.8
3D Structure

Modelled DT Structure

Method: homology modeling

Template PDB: 6GCI_A

Identity: 30.435%

Minimized Score: -514.917 kcal/mol

Detail: Structure Info

Synonyms APC1; MCSC1; Mitochondrial ATP-Mg/Pi carrier protein 1; Mitochondrial Ca(2+)-dependent solute carrier protein 1; SCAMC-1; SCAMC1; SLC25A24; Small calcium-binding mitochondrial carrier protein 1; Solute carrier family 25 member 24
DT Family Mitochondrial Carrier (MC) Family ;
Tissue Specificity Present in various cell lines (at proteinlevel). Expressed in all tissues tested. Highly expressed intestis, expressed at intermediate level in small intestine andpancreas, and weakly expressed in kidney, spleen, liver, skeletalmuscle and heart.
Function This calcium-dependent mitochondrial transporter mediates the reversible, electroneutral exchange of Mg-ATP or Mg-ADP against phosphate ions, catalyzing the net uptake or efflux of adenine nucleotides across the mitochondrial inner membrane. Nucleotide transport is inactive when cytosolic calcium levels are low, and is activated by an increase in cytosolic calcium levels. May play a role in protecting cells against oxidative stress-induced cell death, probably by promoting the formation of calcium-phosphate precipitates in the mitochondrial matrix, and thereby buffering calcium levels in the mitochondrial matrix.
Endogenous Substrate(s) Mg 2+; ATP
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

(ε) Exogenous Modulation of This DT
Exogenous Modulation (EGM)

Structural Variability Data of This DT (VARIDT 2.0)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

General Variability Data of This DT (VARIDT 1.0)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Phosphate
 Approved Drug Info Constipation ME05.0 [1]
References
1 De Novo Mutations in SLC25A24 Cause a Disorder Characterized by Early Aging, Bone Dysplasia, Characteristic Face, and Early Demise. Am J Hum Genet. 2017 Nov 2;101(5):844-855.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.